Inspiremd announces ce mark approval for cguard® prime embolic prevention system (eps) under european mdr for the prevention of stroke

Miami, june 13, 2025 (globe newswire) -- inspiremd, inc. (nasdaq: nspr), developer of the cguard® prime carotid stent system for the prevention of stroke, today announced the company has received ce mark approval under the european medical device regulation (mdr) for the cguard® prime eps.
NSPR Ratings Summary
NSPR Quant Ranking